Impact of age on the cumulative risk of transformation in patients with chronic myelomonocytic leukaemia

Autor: Ernst Ulsperger, Elmir Graf, Reinhard Stauder, Eva Jäger, Klaus Geissler, Heinz Tüchler, Josef Thaler, Ulrich Germing, Peter Valent, Ansgar Weltermann, Christoph Geissler, Sonja Heibl, Renate Marschon, Agnes Barna, Armin Zebisch, Michael Pfeilstöcker, Leopold Öhler, Rajko Kusec, Otto Zach, Bruno Schneeweiss, Michael Gurbisz, Temeida Graf, Peter Bettelheim, Heinz Sill, Sigrid Machherndl-Spandl, Gerald Webersinke, Gregor Hoermann, Thomas Nösslinger
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Adult
Male
medicine.medical_specialty
blast cell count
Leukemia
Myelomonocytic
Chronic / epidemiology

Leukemia
Myelomonocytic
Chronic / mortality

Comorbidity
Lower risk
Competing risks
Myelomonocytic leukaemia
cytogenetics
03 medical and health sciences
0302 clinical medicine
Older patients
Internal medicine
hemic and lymphatic diseases
Biomarkers
Tumor

Odds Ratio
Medicine
score
Humans
In patient
Aged
Aged
80 and over

Leukemia
Myelomonocytic
Chronic / etiology

business.industry
Age Factors
Leukemia
Myelomonocytic
Chronic

Hematology
General Medicine
Original Articles
Middle Aged
mutations
Prognosis
Peripheral blood
Leukemia
Myelomonocytic
Chronic / pathology

Cumulative risk
age
030220 oncology & carcinogenesis
Health Impact Assessment
Life expectancy
Disease Progression
Original Article
Female
Disease Susceptibility
business
chronic myelomonocytic leukaemia
030215 immunology
Zdroj: European Journal of Haematology
ISSN: 1600-0609
0902-4441
Popis: In older patients with chronic myelomonocytic leukaemia (CMML) and limited life expectancy due to age and or comorbidities, it is particularly important to consider the risk of transformation for individualised treatment decisions. There is limited information on potential differences between younger and older CMML patients regarding the cumulative risk of transformation as well as haematological, molecular and biologic characteristics. We analysed data from the Austrian Biodatabase for CMML (ABCMML) to compare these parameters in 518 CMML patients. Categorisation of patients into 3 age‐related groups
Databáze: OpenAIRE
Nepřihlášeným uživatelům se plný text nezobrazuje